… We studied 36 unrelated Japanese patients (24 men and 12 women) with lung cancer,
who attended our hospital from June 1995 to October 1996. The diagnosis of lung cancer was …

… 154 LC patients associated with IPF from reports in the Japanese medical … patients with
synchronous multiple LC (n=49), 131 patients with single LC, and a large cohort of LC patients …

… First, this was a small study that included only Japanese patients treated at a single
institution. Second, our study population was heterogeneous in regard to the treatment regimens …

… A research study reported that about 40% of Japanese patients hope to receive various …
factors in patients with lung cancer in the terminal stage in order to establish lung cancer specific …

We performed a clinical phase II trial of the combination of paclitaxel and cisplatin in patients
with locally advanced (stage IIIB) or metastatic non-small-cell lung cancer (NSCLC) using a …

… Japanese patients with NSCLC who received nivolumab were analyzed retrospectively.
Patients who had started nivolumab treatment between April 2016 and December 2016 were …

… The Japan Guidelines of Lung Cancer Therapy recommend … non-small cell lung cancer
patients with epidermal growth … of non-small cell lung cancer patients with epidermal growth …

… Three Japanese investigators also reported almost comparable data (3.5%, 5.4%, and 5.8%…
events in Japanese patients appear to be higher than those in countries outside Japan (0.3%…

Objective: Gemcitabine and docetaxel are non-platinum agents with activity in non-small
cell lung cancer (NSCLC). This study was conducted to determine and evaluate the …

… the standard treatment of docetaxel in patients with previously treated advanced … lung cancer
(NSCLC). We previously conducted two phase II studies of nivolumab in Japanese patients …